4//SEC Filing
Dummer Wolfgang 4
Accession 0001567619-21-019427
CIK 0001034842other
Filed
Nov 4, 8:00 PM ET
Accepted
Nov 5, 6:59 PM ET
Size
5.9 KB
Accession
0001567619-21-019427
Insider Transaction Report
Form 4
Dummer Wolfgang
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-11-04+37,500→ 37,500 totalExercise: $2.38Exp: 2030-08-25→ Common Stock (37,500 underlying)
Footnotes (2)
- [F1]The reporting person was granted a performance-based option to purchase 37,500 shares of common stock on August 25, 2020. Thus, the exercise price of this option is $2.38 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On November 4, 2021, it was determined that the performance metric had been met.
- [F2]The shares of common stock subject to the option vest in equal monthly installments over twenty-four (24) months from the vesting commencement date of October 25, 2021, subject to the reporting person's continuous service to the issuer through each such period.
Documents
Issuer
RIGEL PHARMACEUTICALS INC
CIK 0001034842
Entity typeother
Related Parties
1- filerCIK 0001749991
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 8:00 PM ET
- Accepted
- Nov 5, 6:59 PM ET
- Size
- 5.9 KB